ACAD·004225108·US·equity·Healthcare - Biotechnology-Activist
ACAD (ACADIA PHARMACEUTICALS INC) is held by 162 institutional investors as of Q1 2026. Largest holders: BAKER BROS. ADVISORS LP ($954.9M), BlackRock, Inc. ($479.7M), STATE STREET CORP ($185.5M). Net institutional sentiment: Mixed.
See how ACAD's score breaks down across 4 SEC sources
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer